LEXOR (Lab of Experimental Oncology and Radiobiology), Center for Experimental Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam 1105AZ, The Netherlands.
Cell Death Differ. 2012 Nov;19(11):1826-35. doi: 10.1038/cdd.2012.68. Epub 2012 Jun 15.
The tumor necrosis factor (TNF) family member APRIL (A proliferation inducing ligand) is a disease promoter in B-cell malignancies. APRIL has also been associated with a wide range of solid malignancies, including colorectal cancer (CRC). As evidence for a supportive role of APRIL in solid tumor formation was still lacking, we studied the involvement of APRIL in CRC. We observed that ectopic APRIL expression exacerbates the number and size of adenomas in Apc(Min) mice and in a mouse model for colitis-associated colon carcinogenesis. Furthermore, knockdown of APRIL in primary spheroid cultures of colon cancer cells and both mouse and human CRC cell lines reduced tumor clonogenicity and in vivo outgrowth. Taken together, our data therefore indicate that both tumor-derived APRIL and APRIL produced by non-tumor cells is supportive in colorectal tumorigenesis.
肿瘤坏死因子(TNF)家族成员 APRIL(增殖诱导配体)是 B 细胞恶性肿瘤的疾病促进剂。APRIL 也与广泛的实体恶性肿瘤有关,包括结直肠癌(CRC)。由于缺乏 APRIL 在实体肿瘤形成中具有支持作用的证据,我们研究了 APRIL 在 CRC 中的参与情况。我们观察到,异位 APRIL 表达加剧了 Apc(Min)小鼠和结肠炎相关结肠癌发生的小鼠模型中腺瘤的数量和大小。此外,在结肠癌细胞的原代球体培养物以及小鼠和人 CRC 细胞系中敲低 APRIL,减少了肿瘤集落形成能力和体内生长。因此,我们的数据表明,肿瘤衍生的 APRIL 和非肿瘤细胞产生的 APRIL 都支持结直肠肿瘤发生。